Dr. Peter-Brian Andersson, a Board Certified Neurologist and Associate Professor of Neurology at UCLA, specializes in Traumatic Brain Injury, Multiple Sclerosis, Complex Regional Pain Syndrome, Memory Disorders, Capacity, and Nursing Home Standard of Care.
Between 1992 and 1997, Dr. Andersson completed an internal medicine internship and then neurology residency at the University of California, San Francisco where he also served as Chief Resident. He has completed fellowships in multiple sclerosis at UCSF and in neuromuscular disease at Stanford University. He served on the faculty at Stanford University in the neuromuscular division before moving to the Valley in 1999 and has served this community as both an outpatient and inpatient neurologist for over 20 years.
Dr. Andersson has been published in laboratory and clinical neurology. He has been an ad hoc reviewer for the journal Muscle & Nerve. He is the Medical Director of Stratus Neurodiagnostics, the leading outpatient EEG services company in the United States, and has served as a Principal and Co-Investigator for dementia trials at The National Research Institute.Epilepsy
Litigation Support: Dr. Andersson has extensive experience providing expert testimony. His services include medical record review, IMEs, thorough reporting, depositions, and trial testimony as needed.
Areas of Expertise:
- Traumatic Brain Injury
- Neuromuscular Disease
- Multiple Sclerosis
- Complex Regional Pain Syndrome
- Capacity
- Epilepsy
| - EMG & EEG
- Neuropathy
- Myopathy
- Headaches
- Dementia / Memory Disorders
- Nursing Home Standard of Care
|
Prior to beginning his residency, Dr. Andersson graduated cum laude in medicine from the University of Cape Town in 1986. In 1988, he earned an honors degree in medical biochemistry at the University of Cape Town. Between 1988 and 1991, Dr. Andersson obtained a D. Phil in neuroimmunology at Oxford University as a Rhodes Scholar. He was Yamanouchi Junior Research Fellow in Cell Biology at Wolfson 1991-2. Junior Research Fellowships are awarded to the top 2% of graduates at Oxford University.